September’s financing results show meaningful capital-raising activity among CSE-listed companies, but private businesses considering a Canadian public listing must distinguish existing-issuer financings from the capital available for a new listing.
At a glance: Five points for prospective issuers
- CSE companies raised $327 million in September. The Exchange reported 88 financings during the month.
- Financing and new listings are different measures. The five new company listings do not account for the Exchange’s entire financing total.
- A small number of issuers influenced the total. The CSE identified financings by BetterLife Pharma and Avanti Gold as significant drivers of September’s result.
- The market’s activity varied by measure. Financing totals rose from August, while reported trading volume and trading value were lower.
- A feasible listing and financing plan remains essential. Private companies need to assess exchange suitability, transaction structure, capital requirements and investor fit before proceeding.
On October 16, 2026, the Canadian Securities Exchange (CSE) released its September 2026 operating statistics. The Exchange reported $327 million in aggregate financing proceeds across 88 financings, along with five new company listings and one fundamental change of business by an existing issuer. It also reported approximately $1.7 billion in equity financings for the first nine months of 2026.
For companies evaluating a Canadian public listing, these results provide useful evidence of actual financing and listing activity. They do not establish that capital will be available to a particular private company, that a financing will occur alongside its listing or that a proposed valuation will be accepted by investors. The commercial question is how to build a listing and financing strategy that is viable for the business itself.
What the CSE’s September 2026 figures show
The Exchange’s reported operating statistics include both capital raised by listed issuers and trading activity in CSE securities. These are separate indicators and should be considered independently.
| CSE operating measure | September 2026 |
|---|---|
| Aggregate financing proceeds | $327 million |
| Number of financings | 88 |
| New company listings | 5 |
| Existing issuer fundamental changes of business | 1 |
| Trading volume | 1.1 billion shares |
| Trading value | $376 million |
| Total listed securities at September 30 | 739 |
Source: CSE September 2026 operating statistics, released October 16, 2026. Amounts are reported as published by the Exchange. The financing total must not be interpreted as capital raised by the five new listings.
The numbers document activity on the Exchange, but they do not identify how much of the aggregate financing was associated with new listing transactions. Nor does the number of completed financings, by itself, measure the success rate of companies attempting to raise capital.
Financing rose from August, but the indicators did not all move together
The CSE’s August 2026 operating report recorded $165 million across 62 financings. September’s corresponding figures were $327 million and 88 financings. Over the same period, trading value moved from $467 million to $376 million and trading volume moved from 1.2 billion to 1.1 billion shares.
There were nine new company listings in August, compared with five in September. The CSE separately reported three fundamental changes of business in August and one in September. These movements should not be collapsed into a single conclusion about overall market strength, because financings, new listings and secondary-market trading measure different activities.
The CSE also reported that first-nine-month equity financing of approximately $1.7 billion exceeded the total for any full calendar year since 2021. That is an important historical statement from the Exchange, but it does not tell a private issuer whether its own proposed offering is financeable today.
The concentration of financings matters
In its September release, the CSE attributed a significant part of the month’s higher aggregate proceeds to equity financings by BetterLife Pharma Inc. and Avanti Gold Corp. The Exchange also identified mining and life sciences as areas of particular strength in year-to-date financing activity.
Those observations require careful interpretation. Financing results can be shaped by the circumstances of particular issuers, including their assets, operating progress, transaction terms, financing participants and existing shareholder bases. A significant financing by an established public company does not establish that a private business at a different stage, or in another sector, will obtain comparable support.
For a management team contemplating a listing, sector relevance is one consideration, but it is not sufficient on its own. The company must be able to explain why capital is required, how it would be deployed and what milestones the proposed financing could reasonably support.
New CSE listings demonstrate more than one route to the public market
September’s five new company listings should be distinguished from the separately reported fundamental change of business. The exchange statistics do not provide a complete breakdown of the listing structure or financing associated with each new issuer, so the total should not be characterized as five IPOs.
One documented example is Pelican AI Corp., whose common shares began trading on the CSE on September 1, 2026, following completion of a reverse takeover and the release of escrowed funds from previous financings. This illustrates how a listing can be connected to an RTO and earlier financing steps rather than a conventional IPO completed on the first trading day.
A prospective issuer may consider an initial public offering, a reverse takeover, or another eligible listing structure. The appropriate method depends on the company’s financial condition, shareholder and capital structure, required disclosure, transaction objectives and applicable securities and exchange requirements.
Trading activity is not the same as capital raised for issuers
September’s reported $376 million in trading value reflects transactions in CSE-listed securities. It is not the same as the $327 million raised through issuer financings. Buying and selling shares in the secondary market generally does not place new funds into a company’s treasury, whereas an issuer financing may provide capital to the issuer subject to the terms and structure of the transaction.
Trading conditions remain relevant to a public-company strategy because shareholders and prospective investors may consider the availability of a market for the securities. However, an exchange-wide monthly trading figure does not establish the liquidity of an individual issuer’s shares. That requires company-specific examination, including its public float, ownership distribution, trading history where available and investor interest.
What private companies can reasonably take from the September results
The data confirm that both financings and new listings occurred on the CSE during September 2026. They do not identify an open financing allocation available to newly public companies or indicate the amount that any prospective listing candidate could raise. The distinction is particularly important where a company needs a substantial financing at the same time as its initial listing.
Management should therefore assess the financing on its own merits. That includes the business’s actual capital requirement, the proposed use of proceeds, funding needed to complete the listing, working capital after closing, shareholder dilution and whether suitable financing participants can be engaged. Financing assumptions should be tested before the transaction timetable and capital structure are finalized.
These questions also apply to a business that does not intend to raise capital immediately upon listing. A publicly traded share quotation may support future capital-markets objectives, but it does not guarantee subsequent financing, liquidity or valuation.
Choosing the CSE requires an exchange and transaction assessment
The CSE may be an appropriate exchange for some entrepreneurial and growth-stage companies, but a listing decision should not be made from one month’s activity statistics. The relevant considerations include the nature of the business, financial resources, public distribution, disclosure obligations, management and governance, shareholder structure and the work required to complete the proposed transaction.
The Exchange’s listing requirements must be assessed for the specific issuer and transaction. In some cases, a standard CSE listing may be appropriate; in others, a different Canadian exchange or listing structure may better support the company’s goals. See Go Public in Canada’s CSE listing overview and Going Public Considerations for additional context.
The listing, audit, legal and financing workstreams should be planned together. A financing proposal may affect ownership and public distribution, while the company’s financial records, reporting obligations and any required transaction approvals can influence execution timing. A sound plan evaluates these dependencies early rather than treating exchange approval and capital raising as automatic consequences of one another.
The strategic decision is whether going public advances the business plan
For the right company, a Canadian public listing can provide a platform from which to seek additional capital, pursue acquisitions, use publicly traded shares as transaction consideration and potentially broaden the shareholder base. Those are possible strategic benefits, not guaranteed results. The costs of operating as a public company and the demands of ongoing disclosure and governance must also be considered.
September’s CSE statistics are useful because they show that listed companies raised capital and new companies entered the public market during the month. The more important decision for a prospective issuer is whether its business, financial position and proposed capital structure support a viable transaction. A defensible strategy should identify the amount of capital required, a suitable route to market, realistic execution conditions and the company’s objectives after listing.
Companies that are seriously considering going public should undertake that review while they still have the flexibility to adjust the structure, financing approach and timetable. They should not proceed solely because a recent exchange report shows a high aggregate financing total.
Considering a CSE listing or financing strategy?
Go Public in Canada assists companies with assessing Canadian stock exchange options, IPOs, reverse takeovers and other suitable going-public structures. We can help management evaluate listing readiness, transaction alternatives, capital requirements and the coordination of the legal, audit, exchange and financing workstreams. Contact us to discuss your company’s going-public objectives.
The statistics cited are historical information published by the CSE and do not establish the financing prospects of any particular issuer. This article provides general information only and is not legal, accounting, investment or securities-dealer advice. A public listing does not guarantee financing, trading liquidity or shareholder returns.